Literature DB >> 26496816

Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis.

Hong-Mei Song1, Ying-Chen Wei2, Nan Li2, Bin Wu1, Na Xie3, Kun-Mu Zhang1, Shi-Zhong Wang4, He-Ming Wang2.   

Abstract

The present study aimed to investigate the effects of Wenyangbushen formula on the mRNA and protein expression levels of vascular endothelial growth factor (VEGF), osteoprotegerin (OPG), receptor activator of nuclear factor (NF)‑κβ ligand (RANK), and RANK ligand (RANKL) in a rabbit model of steroid‑induced avascular necrosis of the femoral head (SANFH). The present study also aimed to examine the potential mechanism underlying the effect of this formula on the treatment of SANFH. A total of 136 New Zealand rabbits were randomly divided into five groups: Normal group, model group, and three groups treated with the traditional Chinese medicine (TCM), Wenyangbushen decoction, at a low, moderate and high dose, respectively. The normal group and positive control group were intragastrically administered with saline. The TCM groups were treated with Wenyangbushen decoction at the indicated dosage. Following treatment for 8 weeks, the mRNA and protein expression levels of VEGF, OPG, RANK and RANKL in the femoral head tissues were determined using reverse transcription‑quantitative polymerase chain reaction and western blot analyses, respectively. The data revealed that Wenyangbushen decoction effectively promoted the growth of bone cells, osteoblasts and chondrocytes, and prevented cell apoptosis in the SANFH. The mRNA and protein expression levels of OPG and VEGF were increased, while the levels of RANK and RANKL were reduced in the necrotic tissue of the model group, compared with those in the normal rabbits. Wenyangbushen treatment prevented these changes, manifested by an upregulation in the expression levels of VEGF and OPG, and downregulation in the expression levels of RANK and RANKL in a dose‑dependent manner. It was concluded that treatment with Wenyangbushen formula alleviated necrosis of the femoral head induced by steroids. It was observed to promote bone cell, osteoblast and chondrocyte growth, as well as prevent cell apoptosis. In addition, it upregulated the expression levels of OPG and VEGF, and inhibited the expression levels of RANK and RANKL. These results suggest the potential use of Wenyangbushen formula as a possible approach for the effective treatment of SANFH.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26496816     DOI: 10.3892/mmr.2015.4478

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.

Authors:  Wu-Xun Peng; Chuan Ye; Wen-Tao Dong; Lei-Luo Yang; Chun-Qing Wang; Ze-An Wei; Jian-Hua Wu; Qing Li; Jin Deng; Jian Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-28

2.  Total flavonoids of Rhizoma drynariae ameliorate steroid‑induced avascular necrosis of the femoral head via the PI3K/AKT pathway.

Authors:  Wenxue Lv; Mingxiu Yu; Qingyi Yang; Peng Kong; Bing Yan
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

3.  Upregulation of osteoprotegerin inhibits tert-butyl hydroperoxide-induced apoptosis of human chondrocytes.

Authors:  Qifeng Ren; Wenfei Zhang; Ping Li; Jianli Zhou; Zhonghao Li; Yang Zhou; Ming Li
Journal:  Exp Ther Med       Date:  2022-05-26       Impact factor: 2.751

4.  Dexamethasone promotes the endoplasmic reticulum stress response of bone marrow mesenchymal stem cells by activating the PERK-Nrf2 signaling pathway.

Authors:  Suoli Cheng; Xueqin Liu; Fan Gong; Xiaoling Ding; Xuebing Zhou; Cuiyun Liu; Fei Zhao; Xiaoliang Li; Jiandang Shi
Journal:  Pharmacol Res Perspect       Date:  2021-05

5.  Protective effect of Agrimonia pilosa polysaccharides on dexamethasone-treated MC3T3-E1 cells via Wnt/β-Catenin pathway.

Authors:  Wei Huang; Shengyang Jin; Wenbo Yang; Shuo Tian; Chunqing Meng; Huan Deng; Hong Wang
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.